|
US4190659A
(en)
*
|
1973-08-27 |
1980-02-26 |
Sandoz, Inc. |
Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4273930A
(en)
*
|
1977-06-20 |
1981-06-16 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4187309A
(en)
*
|
1977-06-20 |
1980-02-05 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4281131A
(en)
|
1977-06-20 |
1981-07-28 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4221797A
(en)
*
|
1978-08-14 |
1980-09-09 |
Sandoz, Inc. |
Dihydroquinoline-one derivatives
|
|
FR2443467A1
(fr)
*
|
1978-12-08 |
1980-07-04 |
Roussel Uclaf |
Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
|
|
FR2482596A1
(fr)
*
|
1980-05-19 |
1981-11-20 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
|
|
US4266050A
(en)
*
|
1980-07-02 |
1981-05-05 |
American Home Products Corporation |
1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
|
|
IE52670B1
(en)
*
|
1981-03-03 |
1988-01-20 |
Leo Ab |
Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
|
|
FR2507602A1
(fr)
*
|
1981-06-12 |
1982-12-17 |
Roussel Uclaf |
Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
HU190796B
(en)
*
|
1981-06-12 |
1986-11-28 |
Roussel Uclaf,Fr |
Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
|
|
FR2523130A1
(fr)
*
|
1982-03-15 |
1983-09-16 |
Roussel Uclaf |
Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2509728A1
(fr)
*
|
1981-07-17 |
1983-01-21 |
Roussel Uclaf |
Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2537139B2
(fr)
*
|
1982-03-15 |
1985-09-20 |
Roussel Uclaf |
Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
|
|
FR2551437B2
(fr)
*
|
1982-06-03 |
1985-10-25 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
|
|
FR2530633A1
(fr)
*
|
1982-06-03 |
1984-01-27 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
|
|
FR2532939A1
(fr)
*
|
1982-09-13 |
1984-03-16 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
|
|
FR2537140B1
(fr)
*
|
1982-12-07 |
1986-07-18 |
Roussel Uclaf |
Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
|
|
SE452170B
(sv)
*
|
1983-10-03 |
1987-11-16 |
Boliden Ab |
Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
|
|
FR2566405B1
(fr)
*
|
1984-06-25 |
1986-09-26 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
|
|
US4602014A
(en)
*
|
1984-07-09 |
1986-07-22 |
Ciba-Geigy Corporation |
Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
|
|
JPH0358559A
(ja)
*
|
1989-07-26 |
1991-03-13 |
Sekisui Chem Co Ltd |
電話システム
|
|
US5175151A
(en)
*
|
1990-09-07 |
1992-12-29 |
Schering Corporation |
Antiviral compounds and antihypertensive compounds
|
|
AU8665991A
(en)
*
|
1990-09-07 |
1992-03-30 |
Schering Corporation |
Antiviral compounds and antihypertensive compounds
|
|
US5179093A
(en)
*
|
1991-05-10 |
1993-01-12 |
Schering Corporation |
Quinoline-diones
|
|
DE4138820A1
(de)
*
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
SE9201076L
(sv)
*
|
1992-04-06 |
1993-10-07 |
Shimon Slavin |
Användningen av gamla läkemedel för behandling av diabetes
|
|
SE9400810D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of Quinoline-3-carboxamide compounds
|
|
SE9400809D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of quinoline-3-carboxamide compounds
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
TWI328009B
(en)
*
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
US8314124B2
(en)
*
|
2004-02-06 |
2012-11-20 |
Active Biotech Ab |
Crystalline salts of quinoline compounds and methods for preparing them
|
|
SE0400235D0
(sv)
*
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
|
US8354427B2
(en)
*
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
RU2528046C2
(ru)
*
|
2004-06-24 |
2014-09-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы транспортеров атф-связывающей кассеты
|
|
LT2489659T
(lt)
*
|
2004-06-24 |
2018-03-26 |
Vertex Pharmaceuticals Incorporated |
Atp rišančios kasetės transporterių moduliatoriai
|
|
WO2006087830A1
(ja)
*
|
2005-02-18 |
2006-08-24 |
Kanebo, Ltd. |
帯状織物構造体およびその製法
|
|
JP5832716B2
(ja)
*
|
2005-10-19 |
2015-12-16 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラキニモドナトリウムの結晶，及びその製造方法
|
|
CA2634113A1
(en)
*
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of abc transporters
|
|
CN101384172B
(zh)
|
2005-12-28 |
2014-05-07 |
沃泰克斯药物股份有限公司 |
N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的固体形式
|
|
BRPI0713694A2
(pt)
*
|
2006-06-12 |
2012-10-30 |
Teva Pharma |
composição farmacêutica, processo para preparar composição farmacêutica, embalagens vedada, métodos para tratar um indivìduo afligido com uma forma de esclerose múltipla, e para aliviar um sintoma de esclerose múltipla em um indivìduo afligido com uma forma de esclerose múltipla, e, uso da composição farmacêutica
|
|
WO2008097976A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
PT2682120T
(pt)
|
2007-12-20 |
2016-11-07 |
Teva Pharma |
Preparações de laquinimod estáveis
|
|
ES2633658T3
(es)
*
|
2008-09-03 |
2017-09-22 |
Teva Pharmaceutical Industries Ltd. |
Moduladores 2-oxo-1,2-dihidro-quinolina de la función inmunitaria
|
|
MX384179B
(es)
|
2009-03-20 |
2025-03-14 |
Vertex Pharma |
Proceso para producir moduladores del regulador de conductancia transmembrana de fibrosis quística.
|
|
KR20160148050A
(ko)
*
|
2009-07-30 |
2016-12-23 |
테바 파마슈티컬 인더스트리즈 리미티드 |
라퀴니모드를 이용한 크론병의 치료
|
|
EP3064206B1
(en)
*
|
2009-08-10 |
2019-03-20 |
Active Biotech AB |
Treatment of huntington's disease using laquinimod
|
|
BR112012021905A2
(pt)
*
|
2010-03-03 |
2015-09-29 |
Teva Pharma |
tratamento de nefrite lúpica usando laquinimod
|
|
PH12012501741A1
(en)
*
|
2010-03-03 |
2012-11-12 |
Teva Pharma |
Treatment of lupus arthritis using laquinimod
|
|
CN105796556A
(zh)
*
|
2010-03-03 |
2016-07-27 |
泰华制药工业有限公司 |
用拉喹莫德和甲氨蝶呤的组合治疗类风湿性关节炎
|
|
CN102267984B
(zh)
*
|
2010-06-04 |
2014-07-30 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
|
|
MX2013004169A
(es)
|
2010-10-14 |
2013-06-05 |
Immunahr Ab |
1, 2-dihidro-4-hidroxi-2-oxo-quinolina-3-carboxanilidas como activadores del receptor de hidrocarburo aromatico.
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
EP2537517A1
(en)
*
|
2011-06-22 |
2012-12-26 |
Active Biotech AB |
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
|
|
AU2012322706A1
(en)
|
2011-10-12 |
2014-05-22 |
Teva Pharmaceutical Industries Ltd. |
Treatment of multiple sclerosis with combination of laquinimod and fingolimod
|
|
BR112014018485A8
(pt)
|
2012-02-03 |
2017-07-11 |
Teva Pharma |
Uso de laquinimod para tratar pacientes com a doença de crohn que falharam com a primeira linha de terapia anti-tnf
|
|
HK1203840A1
(en)
|
2012-02-27 |
2015-11-06 |
沃泰克斯药物股份有限公司 |
Pharmaceutical composition and administration thereof
|
|
TW201400117A
(zh)
|
2012-06-05 |
2014-01-01 |
Teva Pharma |
使用拉喹莫德治療眼發炎疾病
|
|
CN104955522A
(zh)
|
2012-11-07 |
2015-09-30 |
梯瓦制药工业有限公司 |
拉喹莫德胺盐
|
|
AU2014212426B8
(en)
*
|
2013-01-31 |
2018-05-10 |
Vertex Pharmaceuticals Incorporated |
Quinoline and Quinoxaline Amides as Modulators of Sodium Channels
|
|
US9233927B2
(en)
|
2013-03-14 |
2016-01-12 |
Teva Pharmaceutical Industries, Ltd. |
Crystals of laquinimod sodium and improved process for the manufacture thereof
|
|
KR20170005434A
(ko)
|
2014-04-29 |
2017-01-13 |
테바 파마슈티컬 인더스트리즈 리미티드 |
높은 장애 상태를 갖는 재발-완화형 다발성 경화증(rrms) 환자 치료용 라퀴니모드
|
|
AU2015330923B2
(en)
|
2014-10-07 |
2020-03-12 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|